Ventyx Biosciences
Why Robinhood?
You can watch VTYX and buy or sell other stocks, ETFs, and their options commission-free!About VTYX
Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions.
VTYX Key Statistics
Stock Snapshot
As of today, Ventyx Biosciences(VTYX) shares are valued at $14.00. The company's market cap stands at 1B, with a P/E ratio of -9.34.
During the trading day, Ventyx Biosciences(VTYX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Ventyx Biosciences(VTYX) stock has reached 0, versus its average volume of 2.78M.
The stock's 52-week range extends from a low of $0.78 to a high of $15.32.
The stock's 52-week range extends from a low of $0.78 to a high of $15.32.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.